ZBH

Zimmer Biomet Holdings, Inc. NYSE

Healthcare ·Medical - Devices ·US · zimmerbiomet.com

$82.90

After hrs $82.87 +0.24%

Mkt Cap $16.5B

52w Low $79.83 10.8% of range 52w High $108.29

50d MA $93.01 200d MA $95.01

P/E (TTM) 23.3x

EV/EBITDA 11.2x

P/B 1.3x

Debt/Equity 0.6x

ROE 5.5%

P/FCF 12.1x

RSI (14) —

ATR (14) —

Beta 0.61

50d MA $93.01

200d MA $95.01

Avg Volume 2.3M

About

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma prod…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 28, 2026	TNS	1.86	2.09	+12.4%	82.80	-0.9%	-3.3%	-0.4%	+0.1%	—	—	—	—
Feb 10, 2026	TNS	2.38	2.42	+1.7%	91.40	-0.6%	+4.6%	+4.1%	+5.5%	+6.3%	+7.5%	+1.3%	—
Nov 5, 2025	TNS	1.87	1.90	+1.6%	87.55	-1.7%	+1.1%	+1.1%	+1.3%	+1.1%	+2.8%	+7.7%	—
Aug 7, 2025	TNS	1.98	2.07	+4.5%	98.43	+0.6%	+0.8%	+1.6%	+3.4%	+4.9%	+3.7%	+6.4%	—
May 5, 2025	TNS	1.77	1.81	+2.3%	90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%	+1.1%	—
Feb 6, 2025	TNS	2.30	2.31	+0.4%	102.69	+0.2%	-1.7%	-2.2%	-3.6%	-3.6%	-2.7%	+7.8%	—
Oct 30, 2024	TNS	1.74	1.74	+0.0%	109.81	-0.1%	-2.6%	-2.3%	-1.3%	-0.8%	+0.3%	+2.1%	—
Aug 7, 2024	TNS	1.99	2.01	+1.0%	105.81	+0.2%	+2.7%	+2.1%	+1.1%	+3.3%	+2.7%	-0.9%	—
May 2, 2024	TNS	1.87	1.94	+3.7%	118.46	+0.9%	+2.7%	+1.8%	+2.5%	+2.0%	+2.5%	-4.5%	—
Feb 8, 2024	TNS	2.15	2.20	+2.3%	123.04	+0.7%	-0.2%	+2.3%	+0.1%	-1.0%	+1.1%	+4.1%	—
Nov 7, 2023	TNS	1.59	1.65	+3.8%	105.93	+0.0%	-1.0%	-1.7%	-0.5%	-0.1%	+2.0%	+10.7%	—
Aug 1, 2023	TNS	1.82	1.82	+0.0%	132.27	-0.4%	-2.9%	-4.9%	-4.5%	-5.0%	-5.6%	-9.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 29	Citigroup	Maintains	Neutral → Neutral	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Apr 29	JP Morgan	Maintains	Neutral → Neutral	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Apr 29	Truist	Maintains	Hold → Hold	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Apr 29	Citizens	Maintains	Market Outperform → Market Outperform	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Apr 29	Stifel	Maintains	Buy → Buy	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Apr 29	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Apr 29	Barclays	Maintains	Underweight → Underweight	—	$82.80	$82.03	-0.9%	-3.3%	-0.4%	+0.1%	—	—
Mar 23	BTIG	Downgrade	Buy → Neutral	—	$87.87	$88.73	+1.0%	-0.1%	-1.8%	-0.3%	+1.5%	+0.8%
Feb 12	Barclays	Maintains	Underweight → Underweight	—	$95.61	$95.55	-0.1%	-0.4%	+0.9%	+1.6%	+2.8%	+3.8%
Feb 11	Citigroup	Maintains	Neutral → Neutral	—	$91.40	$90.87	-0.6%	+4.6%	+4.1%	+5.5%	+6.3%	+7.5%
Feb 11	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$91.40	$90.87	-0.6%	+4.6%	+4.1%	+5.5%	+6.3%	+7.5%
Feb 10	BTIG	Maintains	Buy → Buy	—	$89.73	$94.15	+4.9%	+1.9%	+6.6%	+6.1%	+7.5%	+8.3%
Feb 10	Needham	Maintains	Hold → Hold	—	$89.73	$94.15	+4.9%	+1.9%	+6.6%	+6.1%	+7.5%	+8.3%
Jan 28	UBS	Maintains	Sell → Sell	—	$85.99	$85.40	-0.7%	-0.3%	+0.0%	+1.3%	+0.3%	+0.2%
Jan 9	Bernstein	Maintains	Market Perform → Market Perform	—	$94.08	$92.99	-1.2%	-1.3%	-2.8%	-6.1%	-5.1%	-5.7%
Jan 8	BTIG	Maintains	Buy → Buy	—	$92.67	$91.94	-0.8%	+1.5%	+0.2%	-1.3%	-4.7%	-3.7%
Jan 5	Evercore ISI	Upgrade	In Line → Outperform	—	$90.02	$90.27	+0.3%	+2.9%	+5.3%	+2.9%	+4.5%	+3.1%
Dec 16	Baird	Downgrade	Outperform → Neutral	—	$92.43	$92.01	-0.5%	-1.6%	-0.9%	-2.2%	-3.6%	-2.8%
Dec 11	Citigroup	Maintains	Neutral → Neutral	—	$93.09	$93.00	-0.1%	-0.7%	-1.6%	-0.7%	-2.3%	-1.6%
Nov 10	Canaccord Genuity	Maintains	Hold → Hold	—	$88.50	$87.96	-0.6%	+0.3%	+0.0%	+1.7%	+2.3%	+1.6%
Nov 6	RBC Capital	Maintains	Outperform → Outperform	—	$87.55	$86.07	-1.7%	+1.1%	+1.1%	+1.3%	+1.1%	+2.8%
Nov 6	Barclays	Maintains	Underweight → Underweight	—	$87.55	$86.07	-1.7%	+1.1%	+1.1%	+1.3%	+1.1%	+2.8%
Nov 6	UBS	Maintains	Sell → Sell	—	$87.55	$86.07	-1.7%	+1.1%	+1.1%	+1.3%	+1.1%	+2.8%
Nov 6	JP Morgan	Downgrade	Overweight → Neutral	—	$87.55	$86.07	-1.7%	+1.1%	+1.1%	+1.3%	+1.1%	+2.8%
Nov 5	Barclays	Maintains	Underweight → Underweight	—	$103.18	$90.66	-12.1%	-15.1%	-14.2%	-14.2%	-14.0%	-14.2%
Nov 5	BTIG	Maintains	Buy → Buy	—	$103.18	$90.66	-12.1%	-15.1%	-14.2%	-14.2%	-14.0%	-14.2%
Oct 22	Canaccord Genuity	Maintains	Hold → Hold	—	$102.69	$103.49	+0.8%	+1.3%	+0.5%	+0.3%	+0.4%	-1.5%
Oct 13	BTIG	Maintains	Buy → Buy	—	$94.71	$94.91	+0.2%	+0.4%	+3.9%	+4.9%	+5.5%	+7.6%
Oct 7	Evercore ISI	Maintains	In Line → In Line	—	$98.83	$99.43	+0.6%	+0.2%	-0.5%	-1.5%	-4.2%	-3.8%
Sep 19	Stifel	Maintains	Buy → Buy	—	$100.21	$101.15	+0.9%	-0.1%	+1.5%	+0.1%	-1.2%	-3.2%
Aug 8	UBS	Maintains	Sell → Sell	—	$98.43	$98.98	+0.6%	+0.8%	+1.6%	+3.4%	+4.9%	+3.7%
Aug 8	Raymond James	Maintains	Outperform → Outperform	—	$98.43	$98.98	+0.6%	+0.8%	+1.6%	+3.4%	+4.9%	+3.7%
Aug 8	RBC Capital	Maintains	Outperform → Outperform	—	$98.43	$98.98	+0.6%	+0.8%	+1.6%	+3.4%	+4.9%	+3.7%
Jul 8	Evercore ISI	Maintains	In Line → In Line	—	$92.57	$92.34	-0.2%	+1.0%	+2.8%	+2.8%	+1.3%	+1.4%
May 12	Canaccord Genuity	Maintains	Hold → Hold	—	$95.21	$96.64	+1.5%	+3.2%	+2.4%	+0.1%	+1.6%	+1.8%
May 7	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$92.27	$92.85	+0.6%	+2.0%	+3.1%	+3.2%	+6.4%	+5.7%
May 6	Baird	Maintains	Outperform → Outperform	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	Goldman Sachs	Maintains	Neutral → Neutral	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	Raymond James	Maintains	Outperform → Outperform	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	JP Morgan	Maintains	Overweight → Overweight	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	RBC Capital	Maintains	Outperform → Outperform	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
May 6	Stifel	Maintains	Buy → Buy	—	$90.48	$90.48	+0.0%	+2.0%	+4.0%	+5.1%	+5.2%	+8.6%
Feb 10	Barclays	Maintains	Underweight → Underweight	—	$100.93	$101.57	+0.6%	-0.5%	-1.9%	-1.9%	-1.0%	-0.4%
Feb 10	Truist	Maintains	Hold → Hold	—	$100.93	$101.57	+0.6%	-0.5%	-1.9%	-1.9%	-1.0%	-0.4%
Feb 7	Raymond James	Maintains	Outperform → Outperform	—	$102.69	$102.94	+0.2%	-1.7%	-2.2%	-3.6%	-3.6%	-2.7%
Feb 7	RBC Capital	Maintains	Outperform → Outperform	—	$102.69	$102.94	+0.2%	-1.7%	-2.2%	-3.6%	-3.6%	-2.7%
Feb 7	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$102.69	$102.94	+0.2%	-1.7%	-2.2%	-3.6%	-3.6%	-2.7%
Feb 7	Needham	Maintains	Hold → Hold	—	$102.69	$102.94	+0.2%	-1.7%	-2.2%	-3.6%	-3.6%	-2.7%

Recent Filings

8-K · 5.02 !!! Very High

Zimmer Biomet Holdings, Inc. -- 8-K 5.02: Executive Change

Zimmer Biomet appointed Suketu Upadhyay as interim CFO and Paul Stellato as principal financial officer while Upadhyay resigned as director, signaling leadership transitions in the orthopedic device company's finance function.

Apr 28

8-K

Zimmer Biomet Holdings, Inc. -- 8-K Filing

Zimmer Biomet reported Q1 2026 financial results with Phipps appointed as Senior Vice President of Chief Legal and Corporate Affairs Officer and Secretary.

Apr 28

8-K · 5.02 !!! Very High

SkinHealth Systems Inc. -- 8-K 5.02: Executive Change

SkinHealth Systems appointed Kenneth Tripp as director and Dr. Sachin Shridharani as Senior Vice President, signaling management strengthening under new leadership.

Apr 22

8-K

Zimmer Biomet Holdings, Inc. -- 8-K Filing

Zimmer Biomet reported full-year 2025 financial results, providing investors with updated performance metrics and operational guidance for the orthopedic device manufacturer.

Feb 10

Data updated apr 27, 2026 11:32am · Source: massive.com